NEW YORK (GenomeWeb) – DiagnoCure announced this week that the proxy advisory firms Institutional Shareholder Services and Glass Lewis have recommended that DiagnoCure shareholders vote to approve the sale of its PCA3 assets to Hologic subsidiary Gen-Probe. The sale was first announced in December — Gen-Probe will pay approximately $4.7 million for the assets. DiagnoCure said it will distribute 95 percent of the cash proceeds to shareholders once they approve the deal. Further, DiagnoCure will also repurchase 4.9 million of its own series A convertible preferred shares from Gen-Probe, which will cancel all preferred shares issued by the company.
Immucor and Sirona Genomics announced this week that they have received the CE mark for their Mia Fora NGS system for HLA typing. The system is a high-resolution HLA typing solution for accurate coverage and analysis of 11 HLA genes. It is adapted for use on the Illumina MiSeq. The companies expect to launch a higher volume testing kit for registry HLA typing later this year.
Qiagen announced this week that its Investigator sample and assay technology kits for human identity testing and the associated manufacturing facilities have met the requirements of the newly published ISO 18385:2016 standard. The standard specifies requirements for the manufacture of products used in the collection, storage and analysis of human DNA during forensic testing.
Sophia Genetics announced this week that it has partnered with the Paoli-Calmettes Institute in France to provide the cancer center with access to its genetic analysis services. The institute will use Sophia's tools to identify and diagnose genetic predispositions and inform decisions on personalized therapies, primarily for patients with breast and ovarian cancers, and for the analysis of BRCA 1 and 2 mutations.
908 Devices announced this week that it has received ISO 9001:2015 certification, which specifies requirements for quality management systems and is designed to ensure high-quality products and services.
In Brief This Week is a selection of news items that may be of interest to our readers but had not previously appeared on the GenomeWeb site.